# Age‐Related Genetic Causal Association Between Asthma and Delirium: A Bidirectional Two‐Sample Mendelian Randomization

**Authors:** Xiaopeng Wang, Guangquan Guo, Jinfeng Liu

PMC · DOI: 10.1002/brb3.71198 · Brain and Behavior · 2026-01-28

## TL;DR

This study finds no genetic link between asthma and delirium, suggesting previous connections may be due to non-genetic factors.

## Contribution

The study uses bidirectional Mendelian randomization to assess age-related genetic causality between asthma and delirium.

## Key findings

- No significant genetic causal relationship was found between asthma and delirium in either direction.
- Adjusting for confounders like smoking and BMI did not change the lack of significant associations.
- Age-stratified analyses also showed no significant genetic links between asthma subtypes and delirium.

## Abstract

Despite observational studies suggesting a link between asthma and delirium, establishing a definitive causal relationship has been challenging. This study aims to investigate the genetic causality between these conditions, with a particular focus on age‐related genetic associations using data from large‐scale genome‐wide association studies (GWASs).

Bidirectional two‐sample Mendelian Randomization (MR) analyses were performed using GWAS summary statistics to evaluate the genetic association between asthma (overall, adult‐onset, childhood‐onset, and age at asthma diagnosis) and delirium. The inverse variance‐weighted (IVW) method was the primary analytic approach, supplemented by weighted median, weighted mode, and MR‐Egger methods. Multivariable Mendelian Randomization (MVMR) analyses were conducted to adjust for major confounders, including smoking, body mass index (BMI), alcohol intake, and education. Sensitivity analyses included MR‐Egger regression, MR‐PRESSO outlier tests, Cochran's Q for heterogeneity, and leave‐one‐out analyses.

The primary MR analyses found no evidence of a significant genetic causal relationship between asthma and delirium in either direction (asthma to delirium: IVW OR = 1.02, 95% CI: 0.79–1.32, p = 0.86; delirium to asthma: IVW OR = 1.05, 95% CI: 0.99–1.11, p = 0.13). Age‐stratified MR analyses for adult‐onset and childhood‐onset asthma, as well as age at asthma diagnosis, also showed no significant associations with delirium risk. In MVMR analyses adjusting for smoking, BMI, alcohol intake, and education, the direct effects of asthma and its subtypes on delirium, and of delirium on asthma phenotypes, remained non‐significant (all p > 0.05). Sensitivity analyses confirmed the robustness of these results, with no evidence of pleiotropy or heterogeneity.

These comprehensive bidirectional MR and MVMR analyses do not support a genetic causal association between asthma and delirium, even after adjusting for key confounders and across age‐related asthma subtypes. These findings suggest that previously observed associations may be attributable to non‐genetic factors. Future studies integrating clinical and biomarker data are warranted to further explore these relationships.

Mendelian randomization (MR) study finds no genetic evidence supporting a causal relationship between asthma and delirium across all age groups, challenging previous observational associations.

## Linked entities

- **Diseases:** asthma (MONDO:0004979), delirium (MONDO:0045057)

## Full-text entities

- **Genes:** IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, IL6R (interleukin 6 receptor) [NCBI Gene 3570] {aka CD126, HIES5, IL-1Ra, IL-6R, IL-6R-1, IL-6RA}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** diabetes (MESH:D003920), chronic (MESH:D002908), hypoxemia (MESH:D000860), asthmatic (MESH:D013224), sleep (MESH:D012893), diseases (MESH:D004194), cognitive decline (MESH:D003072), cardiovascular disease (MESH:D002318), Delirium (MESH:D003693), chronic kidney disease (MESH:D051436), inflammation (MESH:D007249), MVMR (MESH:C562757), infections (MESH:D007239), osteoarthritis (MESH:D010003), obesity (MESH:D009765), frailty (MESH:D000073496), delusions (MESH:D063726), neuropsychiatric disorders (MESH:D001523), sensory deficits (MESH:D012678), neuroinflammation (MESH:D000090862), hallucinations (MESH:D006212), neurotoxicity (MESH:D020258), inflammatory bowel disease (MESH:D015212), condition (MESH:D020763), Asthma (MESH:D001249)
- **Chemicals:** oxygen (MESH:D010100), alcohol (MESH:D000438), beta2 agonists (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs11121240, rs11078928, rs7571327

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12848525/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12848525/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12848525/full.md

---
Source: https://tomesphere.com/paper/PMC12848525